|
Volumn 37, Issue 4, 2005, Pages 281-286
|
How we have treated and cared patients with Duchenne muscular dystrophy and severe congestive heart failure
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANXIOLYTIC AGENT;
BENZODIAZEPINE;
DIAZEPAM;
ETIZOLAM;
HALOPERIDOL;
MORPHINE;
NEUROLEPTIC AGENT;
NONSTEROID ANTIINFLAMMATORY AGENT;
PENTAZOCINE;
PHOSPHODIESTERASE;
TRAZODONE;
ANXIETY DISORDER;
ARTICLE;
BLOOD PRESSURE;
CONGESTIVE HEART FAILURE;
CONVALESCENCE;
DIET THERAPY;
DUCHENNE MUSCULAR DYSTROPHY;
ELECTROCARDIOGRAPHY MONITORING;
FEEDING BEHAVIOR;
HOSPITAL;
HUMAN;
MEDICAL STAFF;
PAIN;
PATIENT CARE;
PATIENT MONITORING;
PHYSICAL DISABILITY;
PRACTICE GUIDELINE;
QUALITY OF LIFE;
REST;
RESUSCITATION;
RETROSPECTIVE STUDY;
SEDATION;
SUPPORT GROUP;
TERMINAL CARE;
ADOLESCENT;
ADULT;
ANALGESICS, OPIOID;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
ANXIETY;
CAREGIVERS;
FEMALE;
HEART FAILURE, CONGESTIVE;
HUMANS;
MALE;
MUSCULAR DYSTROPHY, DUCHENNE;
QUALITY OF LIFE;
QUESTIONNAIRES;
RETROSPECTIVE STUDIES;
TERMINAL CARE;
TRANQUILIZING AGENTS;
|
EID: 22444443378
PISSN: 00290831
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (1)
|
References (12)
|